The impact of a shared pharmaceutical supply chain model on counterfeit drugs, diverted drugs, and drug shortages

Portland International Conference on Management of Engineering and Technology

Volumn 2015-September, Issue , 2015, Pages 1879-1889

  Choi, Jae Bong ^a   Rogers, Jamie ^a   Jones, Erick C ^a  

^a The University of Texas at Arlington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRIME; PUBLIC HEALTH;

COUNTERFEIT DRUGS; CURRENT PROBLEMS; ILLEGAL ACTIVITIES; INTEGRATED SYSTEMS; PHARMACEUTICAL SUPPLY CHAINS; PUBLIC HEALTH SYSTEMS; TRACKING SYSTEM; UNITED STATES OF AMERICA;

SUPPLY CHAINS;

EID: 84955605524     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/PICMET.2015.7273165     Document Type: Conference Paper

References (29)

1. Alesso, Luis;Sánchez, Maria José, "Pharmacovigilance Update," WHO Drug Information, vol. 22, pp. 276-281, 2008
2. P. V. Arnum, "EPedigree in the Pharmaceutical Supply Chain," Ptarmacetitical Technology, pp. 36-39, 2008
3. M. Bethesda, "Summary of the executive session on critical threats to the pharmacy supply chain and the effects on patient care," Am J Health-Syst Pharm, vol. 70, pp. 1689-98, Oct. 2013
4. FDA. (2005, Aug.) www.fda.gov. [Online]. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/200 5/ucm108483.htm
5. FDA. (2012, July) www.fda.gov. [Online]. http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDr ugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/FDA SIA/ucm313121.htm
6. FDA. (2013, Oct.) www.fda.gov. [Online]. http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UC M372566.pdf
7. FDA. (2014, Sep.) www.fda.gov. [Online]. http://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Staf fPoliciesandProcedures/ucm079936.pdf
8. FDA. (2011, Sep.) www.fda.org. [Online]. http://www.fda.gov/downloads/Drugs/DrugSafety/DrugIntegrityandSu pplyChainSecurity/UCM272150.pdf
9. J. Golembiewski, "Drug Shortages in the Perioperative Setting: Causes, Impact, and Strategies," Journal of PeriAnesthesia Nursing, vol. 27, pp. 286-292, Aug. 2012
10. GS1. (2012) www.gs1.org. [Online]. http://www.gs1.org/docs/GS1-SupplyChainVisibility-WhitePaper.pdf
11. Neil H.Mermelstein, "Moving Ahead on Traceability," FOODTECHNOLOGY, pp. 98-104, June 2011
12. G. Harris. (2008, Apr.) U.S. Identifies Tainted Heparin in 11 Countries. [Online]. http://www.nytimes.com/2008/04/22/health/policy/22fda.html
13. G. Harris and W. Bogdanich. (2008, Mar.) Contaminant found in China-linked blood thinner. [Online]. http://www.nytimes.com/2008/03/06/business/worldbusiness/06iht-06heparin.10755857.html
14. ims. (2013, Mar.) Accelerated Recovery Initiative Managing Drugs in Short Supply. [Online]. http://xavierhealth.org/wpcontent/ uploads/Barnes-Drug-Shortages1.pdf
15. Jurgen Muller, Conrad Popke, Michaela Urbat, Alexander Zeier, and Hasso Plattner, "A Simulation of the Pharmaceutical Supply Chain to Provide Realistic Test Data," in 2009 First International Conference on Advances in System Simulation, 2009
16. kff. (2012) www.kff.org. [Online]. http://kff.org/other/stateindicator/ total-sales-for-retail-rx-drugs/#map
17. Kwang, N. G; Choi, Y. J; Park, S. G; Jun C. W, "The Development of e-Pedigree Model for Securing Transparent Pharmaceutical Distribution Channel in Korea," in ICHIT 2012, 2012, pp. 226-234
18. I. Lancaster. (2008, Apr.) pharmtech.com. [Online]. http://www.pharmtech.com/trends-holograms-and-anticounterfeiting
19. Ma, C. M; Chiu, Y. H; Chen, C. C; Tsai, R. L;, "Design an e-Pedigree Service for Healthcare Environment using Cloud Computing Technology," in International Conference on Innovation and Management, Kuala Lumpur, Malaysia, 2011
20. D. MILLER, "FOOD PRODUCT TRACEABILITY: NEW CHALLENGES NEW SOLUTIONS," FOODTECHNOLEGE, pp. 33-36, Jan. 2009
21. NABP. (2013, Aug.) www.nabp.net. [Online]. http://www.nabp.net/system/rich/rich-files/rich-files/000/000/064/origi nal/wholesale-drug-distribution-protecting-The-integrity-of-The-nationsprescription-drug-supply.pdf
22. S. F. Paparella, "DRUG SHORTAGES IN THE EMERGENCY DEPARTMENT: MANAGING A THREAT TO PATIENT SAFETY," JOURNAL OF EMERGENCY NURSING, vol. 38, no. 5, pp. 466-469, Sep. 2012
23. Paul Chilcutt; et al;, "Integrity of the pharmaceutical supply chain:Product sourcing for patient safety," Am J Health Syst-Pharm, vol. 61, pp. 1889-94, Sep. 2004
24. pfizer. (2007, Dec.) "Case Study: Lipitor® US Recall". [Online]. www.pfizer.com
25. E. T. Schneiderman. (2006, Aug.) "Charges Announced In $70 Million Drug Diversion Case". [Online]. http://www.ag.ny.gov/pressrelease/ charges-announced-70-million-drug-diversion-case
26. L. A. Stokowski. (2008, Mar.) www.medscape.org. [Online]. www.medscape.org/viewarticle/572103
27. T. Sullivan. (2012, Sep.) "Policy and Medicine". [Online]. http://www.policymed.com/2012/09/ftc-approves-acceleratedrecovery-initiative-to-reduce-drug-shortages.html
28. P. Taylor. (2013, Dec.) "Obama signs Drug Quality and Security Act into law". [Online]. http://www.securingindustry.com/pharmaceuticals/obama-signs-drugquality-and-security-act-into-law/s40/a1906/#.VMQDpv55qQs
29. M. Whitworth. (2012, Mar.) Ensuring Traceability of Clinical Information. Advantage Business Media. [Online]. www.dddmag.com